Alkali Metals Limited (NSE India Code : ALKALI)       STRONG BUY

Company Name :
 NSE SYMBOL :  
Enter Company Name or NSE Code

ALKALI Technical Levels

Resistance 2 32.22
Resistance 1 30.88
PIVOT 29.17
Support 1 27.83
Support 2 24.78

ALKALI Fundamentals

Earning Growth -99.99%
Profit Margin -4.18
PE -10.72
EPS -2.44
Quarter 30-Sep-11

ALKALI Futures

Close
Contracts Traded
Open Interest(OI)
Change in OI
Lot Size

ALKALI Options

Most Active Call
Most Active Put
Highest OI Call
Highest OI Put
Expiry Date

ALKALI Technical Levels


Other Stocks from Pharmaceuticals Sector  AARTIDRUGS   ABBOTINDIA   AJANTPHARM   ALCHEM   ALKALI   ALPA   AMRUTANJAN   ANKURDRUGS   ARL   ASTRAZEN   AUROPHARMA   AVENTIS   BALPHARMA   BIOCON   BLISSGVS   CADILAHC   CELESTIAL   CIPLA   DISHMAN   DIVISLAB   DRREDDY   ELDERPHARM   FDC   FKONCO   GLAXO   GLENMARK   GRANULES   INDOCO   INDSWFTLAB   INDSWFTLTD   IPCALAB   JAGSNPHARM   JBCHEPHARM   JUBILANT   KILITCH   KOPRAN   LUPIN   LYKALABS   MANGALAM   MERCK   MOREPENLAB   NATCOPHARM   NECLIFE   NEULANDLAB   OPTOCIRCUI   ORCHIDCHEM   PANACEABIO   PARABDRUGS   PFIZER   PIRHEALTH 

ALKALI Share Price on 5-10-2012

Open 29.95
High 29.95
Low 28.25
Close 28.4
Volume 8323
Change -0.75 (-2.57%)
Series EQ
Date of Listing 06-Nov-08
Paid Up Value 10
Face Value 10
Market Capital 0 Crores
52 Week High/Low 48 / 23.2
Get share widget

Alkali Metals Limited Company Profile

Alkali Metals is an ISO 14001:2004 and ISO 9001:2000 certified company engaged in the business of manufacturing a range of fine chemicals, based on related chemistry. The company was incorporated on April 17, 1968 in a joint venture with APIDC. It commenced the production of sodium metal, with an installed capacity of 125 MT. The company developed the technology for sodium metal based on in-house R & D capabilities. It enjoys a distinction of developing technology for the manufacture of sodium metal for usage in fast breeder nuclear reactors for power generation. Company?s diversified product portfolio can be classified into the three categories- Sodium derivatives, pyridine derivatives and fine chemicals. Products in these categories include amides, hydrides, alkoxides, azides, tetrazoles, pyridine compounds, cyclic compounds, drug and pharma intermediates, specialty fine chemicals etc. The company manufactures these products on bulk and regular basis, on campaign basis and also on contract manufacturing basis. Company?s customer kitty includes some of the leading global pharma majors like Dr. Reddys Laboratories, Aurobindo Pharma, Ranbaxy, Clariant, Novasep and Siber Hegner. The company also has a dedicated R&D facility recognized by the Ministry of Science and Technology, New Delhi. Currently, the company has two manufacturing facilities, Unit I and II. Both these units are ISO 9001: 2000 and ISO 14001:2004 certified and both are having the installed capacity of 2,200 MTPA each. While Unit I is engaged in the manufacture of sodium metals, organo alkali metallics, tetrazoles, amino pyridines and caters to the domestic market, Unit II, a 100% EOU is engaged in the manufacture of pyridine derivatives, cyclic compounds and fine chemicals. The registered office of our Company is located at B-5, Block III, Industrial Development Area, Uppal, Hyderabad-500 039, Andhra Pradesh, India. Financials The company registered a marginal increase in its net profit for the year ended March 31, 2008. The profit of the company rose 4.30% to Rs 79.32 million as against Rs 76.05 million for the year ended March 31, 2007. Net Sales rose 2.93% to Rs 617.68 million, while total income for the year rose 2.09% to Rs 653.35 million as against Rs 640 million for the previous year period.

ALKALI Intraday Realtime Chart

ALKALI Corporate Announcements

DATE PURPOSE
30-Jul-12 Outcome of Annual General Meeting
30-Jul-12 Financial Result Updates
21-May-12 Book Closure
21-May-12 Dividend
21-May-12 Financial Result Updates

ALKALI Corporate Actions

DATE PURPOSE
25-Jul-12 Annual General Meeting And Dividend - Rs.1/- Per Share
25-Jul-12 AGM/DIV-RS.1/- PER SHARE
26-Jul-11 Annual General Meeting And Dividend Rs.2/- Per Share
26-Jul-11 AGM/DIV-RS.2/- PER SHARE

ALKALI Board Meetings

MEETING DATE PURPOSE
30-Jul-12 Results/Others
21-May-12 Results/Dividend
06-Feb-12 Results/Others
11-Nov-11 Results/Others
30-Jul-11 Un-audited Financial Results

ALKALI Related companies

Symbol Company Name
AARTIDRUGS Aarti Drugs Limited
ABBOTINDIA Abbott India Limited
AJANTPHARM Ajanta Pharma Limited
ALCHEM Alchemist Limited
ALKALI Alkali Metals Limited

Most Active NSE INDIA Stocks

 HDFC   LITL   IVRCLINFRA   HDIL   UNITECH   JPASSOCIAT   GVKPIL   TATAMOTORS   IFCI   IBREALEST   ESSAROIL   GMRINFRA   BIRLAPOWER   HINDALCO   BHEL   RENUKA   RCOM   DLF   SUZLON   RELCAPITAL   IDFC   ADANIENT   ITC   TATAPOWER   BALLARPUR 

Free Stock Market Tips:

VJonDalalStreet Paid Tips

Home
Stock Market IPO
Mutual Funds
Education Paid Service
About us
Share Market
IPO Watch
MF News
IPO
Subscription
VJonDalalStreet
Technical Analysis
New IPO Review
Old Funds
Articles
Equity Performance
DalalStreet Blog
Stock Market News Indian IPO News
New Funds
Stock Market
Futures Performance
Free Sms Alerts
World Stock Market
IPO Allotment Status
Best Funds
Financial Terms
Options Performance
Privacy Stock Recommendations
Grey Market Premium MF Analysis Futures & Options Jackpot Performance
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither VJonDalalStreet.com website nor any of its promoters shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes acceptance of our Disclaimer
Follow VJonDalalStreet on Facebook Follow VJonDalalStreet on Twitter Follow VJonDalalStreet Blog Email VJonDalalStreet